Alert: The Plaza Building will remain closed through Jan. 20, 2025.
The Plaza Building will remain closed through Jan. 20, 2025. The Health Center is operating in a modified capacity. Call 303-615-9999 for appointment information during operating hours. Reminder, the Health Center is closed for the winter break Dec. 24 - Jan. 1.
Learn More
September 7, 2022 Research Bulletin
Volume 3, Issue 17
Dear Colleagues,
I am pleased to announce Laura Buccini, DrPH, MPH in her role as Senior Director for Research Development at the CU Anschutz Medical Campus starting September 1st, 2022. Dr. Buccini has been supporting research development at the Cleveland Clinic for the last 10 years, most recently as the Director of Research Development and Strategic Initiatives. During her tenure there, she has led initiatives to elevate the Cleveland Clinic’s competitiveness for research partnerships and funding.
Over the next several months, Dr. Buccini will work to develop a strong understanding of our campus’s research strengths and unique assets, reaching out to many researchers and research units. After her initial research landscape assessment, we will work to strategically anticipate and plan for future research funding opportunities, including with ARPA-H, DOD offerings and other new national research directions.
Please join me in welcoming Dr. Buccini to our campus. Her experience and knowledge in this area provides a real opportunity for additional planning for new national research opportunities going forward.
Sincerely,
Thomas Flaig, MD
Vice Chancellor for Research
I am pleased to announce Laura Buccini, DrPH, MPH in her role as Senior Director for Research Development at the CU Anschutz Medical Campus starting September 1st, 2022. Dr. Buccini has been supporting research development at the Cleveland Clinic for the last 10 years, most recently as the Director of Research Development and Strategic Initiatives. During her tenure there, she has led initiatives to elevate the Cleveland Clinic’s competitiveness for research partnerships and funding.
Over the next several months, Dr. Buccini will work to develop a strong understanding of our campus’s research strengths and unique assets, reaching out to many researchers and research units. After her initial research landscape assessment, we will work to strategically anticipate and plan for future research funding opportunities, including with ARPA-H, DOD offerings and other new national research directions.
Please join me in welcoming Dr. Buccini to our campus. Her experience and knowledge in this area provides a real opportunity for additional planning for new national research opportunities going forward.
Sincerely,
Thomas Flaig, MD
Vice Chancellor for Research
Featured Funding Opportunities
- 09/19/22 - The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional)
- 10/05/22 - Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed)
- 10/05/22 - AD/ADRD, Adverse Childhood Experiences, and Social Determinants of Health Ancillary Studies of Existing Longitudinal Cohorts (R01 - Clinical Trial Not Allowed)
- 10/12/22 - AHRQ Mentored Clinical Scientist Research Career Development Award (K08)
- 11/04/22 - Training Award to Promote Cross-Training in the Fields of Traumatic Brain Injury (TBI) as a Risk Factor for Alzheimer’s Disease/Alzheimer’s Disease Related Dementias(AD/ADRD) (K18 Clinical Trial Not Allowed)
- 11/10/22- REsearch Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed)
- 11/14/22- NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional)
- 11/14/22 - NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R01 Clinical Trial Optional)
- 11/14/22 - NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)
- 11/17/22 - Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
- 11/30/22 - Transplantation Statistical and Clinical Coordinating Center (T-SCCC) (U01 Clinical Trial Not Allowed)
- 11/30/22 - Reproductive Scientist Development Program (RSDP) (K12 Clinical Trial Not Allowed)
- 12/01/22 - MPRINT Translational Research Resource Platform (TRRP) (U24 Clinical Trial Not Allowed)
- 12/05/22 - Maternal Health Research Centers of Excellence (U54 Clinical Trial Optional)
- 03/03/23 - NIAMS Clinical Trial Planning Grant (R34) - Clinical Trial Not Allowed
NIH Funding Announcements
NIH funding opportunities and notices are presented weekly. Please see the current and past updates below.
Limited Funding Opportunities
To submit a proposal for these opportunities: Interested candidates must send a one-page summary of their research proposal and their biosketch in pdf format via the Limited Submission Portal
The NCI Predoctoral to Postdoctoral Fellow Transition Award
- Materials due to Internal Review Committee: September 20, 2022
- Sponsor Deadline: November 18, 2022
National Institute of Allergy and Infectious Diseases (NIAID) Clinical Data and Safety Management Center (CDSMC)
- Materials due to Internal Review Committee: September 27, 2022
- Sponsor Deadline: November 30, 2022
Special Announcements
The Strategic Infrastructure for Research Committee (SIRC) is announcing a new pilot grant program: “Across the Finish Line” (AFL) grants, designed to help both junior faculty and established faculty moving into a new area of investigation.
Funds will be used to generate pilot data that can be leveraged into a new R01-type grant submission (or re-submission). Initially, grants will be reviewed by the standing SIRC review committee. Questions and applications should be submitted by 5pm on Wednesday, August 17, 2022, to Peter Buttrick.
The Translational Methods Pilot Grant supports the development of novel methods and innovative technologies for clinical and translational medicine to address translational science roadblocks. This includes the development of new assays, methods, software, technologies and animal models which are not currently available to the CU Anschutz campus and CCTSI affiliated institutions.
The Request for Applications is now open, with a mandatory intent to apply submission deadline of September 26, 2022.Integrated and well-managed biomedical data is key to driving research; therefore, the Research Informatics Office (RIO) was established to coordinate and integrate data and analytic capabilities across the Anschutz Medical Campus. The newly instantiated CRIO Council aims to understand our data landscape via a survey.
This inventory of research needs and data has several benefits to researchers: potential for better, easier, or less expensive data management solutions; improved data reuse and cost-effectiveness for commonly utilized datasets; identification of new research opportunities and collaborations; easier compliance to the new NIH data sharing policy; analytical infrastructure for research and educational use; and enabling the RIO to best support grant applications - especially program projects or data coordination centers.
We urge you to share information regarding your needs and assets at this 10-min survey so that the Council can best plan the future of research infrastructure on the Anschutz Campus. Please complete the survey by September 15th.
The CRIO Council will distribute summary results by October 31st, along with plans for campus infrastructure.
Feel free to contact crio@cuanschutz.edu with any questions.
Flier with FAQs. Deadline: September 16, 2022
For more information contact Gina.Daly@cuanschutz.edu.
The Translational Methods Pilot Grant supports the development of novel methods and innovative technologies for clinical and translational medicine to address translational science roadblocks. This includes the development of new assays, methods, software, technologies and animal models which are not currently available to the CU Anschutz campus and CCTSI affiliated institutions.
See this flier for more information, or visit sparkcu.org.This bulletin is distributed on the 1st & 3rd Tuesday of the month for the CU Anschutz Research Community.
Past Research Bulletins can be found here.
Please click here if you wish to be added to this distribution.